Atlas Trials

The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19

Clinical trial NCT04291053 · UNKNOWN

Trial details

NCT number
NCT04291053
Sponsor
Tongji Hospital
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-04-01
Primary completion
2020-08-01
Enrollment
550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.